SHANDONG TEAMGENE TECHNOLOGY CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.12 CNY | -.--% |
|
-10.32% | -13.06% |
Valuation
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Capitalization 1 | 3,535 | 2,535 | 2,204 | - | - |
| Enterprise Value (EV) 1 | 3,535 | 2,535 | 2,204 | 2,204 | 2,204 |
| P/E ratio | 23.3 x | 30.2 x | 18 x | 12.8 x | 11.1 x |
| Yield | - | 1.33% | 1.52% | 1.14% | - |
| Capitalization / Revenue | 2.13 x | 1.54 x | 1.01 x | 0.88 x | 0.69 x |
| EV / Revenue | 2.13 x | 1.54 x | 1.01 x | 0.88 x | 0.69 x |
| EV / EBITDA | 25.5 x | 20.1 x | 12.2 x | 9.88 x | 8.02 x |
| EV / FCF | - | -8.06 x | 9.03 x | 17.5 x | - |
| FCF Yield | - | -12.4% | 11.1% | 5.72% | - |
| Price to Book | 2.88 x | 2.06 x | 1.67 x | 1.42 x | 1.42 x |
| Nbr of stocks (in thousands) | 168,000 | 168,000 | 168,000 | - | - |
| Reference price 2 | 21.04 | 15.09 | 13.12 | 13.12 | 13.12 |
| Announcement Date | 30/03/23 | 26/04/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net sales 1 | - | 1,658 | 1,647 | 2,181 | 2,502 | 3,182 |
| EBITDA 1 | - | 138.7 | 126 | 180 | 223 | 275 |
| EBIT 1 | - | 126 | 99.3 | 145 | 200 | 234 |
| Operating Margin | - | 7.6% | 6.03% | 6.65% | 8% | 7.35% |
| Earnings before Tax (EBT) 1 | - | 137.8 | 99.79 | 144 | 200 | 233 |
| Net income 1 | 145.8 | 120.3 | 83.89 | 123 | 173 | 199 |
| Net margin | - | 7.25% | 5.09% | 5.64% | 6.92% | 6.25% |
| EPS 2 | 1.157 | 0.9045 | 0.4993 | 0.7300 | 1.025 | 1.180 |
| Free Cash Flow 1 | - | - | -314.4 | 244 | 126 | - |
| FCF margin | - | - | -19.1% | 11.19% | 5.04% | - |
| FCF Conversion (EBITDA) | - | - | - | 135.56% | 56.5% | - |
| FCF Conversion (Net income) | - | - | - | 198.37% | 72.83% | - |
| Dividend per Share 2 | - | - | 0.2000 | 0.2000 | 0.1500 | - |
| Announcement Date | 22/09/22 | 30/03/23 | 26/04/24 | - | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | - | - | -314 | 244 | 126 | - |
| ROE (net income / shareholders' equity) | - | 20.1% | 6.87% | 9.3% | 11.1% | 12.8% |
| ROA (Net income/ Total Assets) | - | 12.4% | - | 8.3% | 9.5% | 10.7% |
| Assets 1 | - | 970.6 | - | 1,482 | 1,821 | 1,860 |
| Book Value Per Share 2 | - | 7.310 | 7.310 | 7.840 | 9.240 | 9.240 |
| Cash Flow per Share | - | 0.3500 | - | - | - | - |
| Capex 1 | - | 172 | 260 | 100 | 40.5 | 50 |
| Capex / Sales | - | 10.39% | 15.8% | 4.59% | 1.62% | 1.57% |
| Announcement Date | 22/09/22 | 30/03/23 | 26/04/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
13.12
CNY
Average target price
18
CNY
Spread / Average Target
+37.20%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -13.06% | 304M | |
| +12.80% | 11.59B | |
| +7.51% | 6.25B | |
| +3.48% | 5.25B | |
| -21.81% | 2.65B | |
| +3.62% | 1.94B | |
| -9.60% | 1.33B | |
| -11.80% | 937M | |
| -23.72% | 882M | |
| +21.84% | 835M |
- Stock Market
- Equities
- 603151 Stock
- Financials Shandong Teamgene Technology Co., Ltd.
